In monkeys, elevating ambient temperature has been shown to increase sensitivity to 3,4-methylenedioxymethamphetamine (MDMA) reinforcement. Earlier rodent studies have shown that elevations in thyroid levels (hyperthyroidism) parallel changes in elevating the ambient temperature on MDMA-induced thermogenesis, but the interaction has not been examined in monkeys. This study was designed to evaluate the effects of chronic levothyroxine (3.0 or 4.5 lg/kg/day, intramuscularly; Levo) treatment on MDMA-induced increases in body temperature following 1.5 mg/kg (intravenously) MDMA and self-administration when MDMA (0.03-0.3 mg/kg/injection) and food were available under a concurrent fixed-ratio 30 schedule of reinforcement in rhesus monkeys (n = 4). Earlier studies had shown that 1.5 mg/kg MDMA did not affect thermoregulation at 248C. Chronic Levo treatment resulted in significant increases in MDMA-induced thermogenesis. In the self-administration experiment, MDMA choice increased with dose, such that food was preferred over saline and a low MDMA dose (0.03 mg/kg/injection), whereas 0.1 and 0.3 mg/kg/ injection MDMA was preferred over food. Although elevating ambient temperature had been shown to increase MDMA potency, there was no effect of chronic Levo treatment on MDMA choice. These results suggest that changes in thyroxine levels do not parallel the changes in ambient temperature in altering the reinforcing strength of MDMA.
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In monkeys, elevating ambient temperature has been shown to increase sensitivity to 3,4-methylenedioxymethamphetamine (MDMA) reinforcement. Earlier rodent studies have shown that elevations in thyroid levels (hyperthyroidism) parallel changes in elevating the ambient temperature on MDMA-induced thermogenesis, but the interaction has not been examined in monkeys. This study was designed to evaluate the effects of chronic levothyroxine (3.0 or 4.5 lg/kg/day, intramuscularly; Levo) treatment on MDMA-induced increases in body temperature following 1.5 mg/kg (intravenously) MDMA and self-administration when MDMA (0.03-0.3 mg/kg/injection) and food were available under a concurrent fixed-ratio 30 schedule of reinforcement in rhesus monkeys (n = 4). Earlier studies had shown that 1.5 mg/kg MDMA did not affect thermoregulation at 248C. Chronic Levo treatment resulted in significant increases in MDMA-induced thermogenesis. In the self-administration experiment, MDMA choice increased with dose, such that food was preferred over saline and a low MDMA dose (0.03 mg/kg/injection), whereas 0.1 and 0.3 mg/kg/ injection MDMA was preferred over food. Although elevating ambient temperature had been shown to increase MDMA potency, there was no effect of chronic Levo treatment on MDMA choice. These results suggest that changes in thyroxine levels do not parallel the changes in ambient temperature in altering the reinforcing strength of MDMA. Introduction 3,4-Methylenedioxymethamphetamine (MDMA)-induced thermogenesis and reinforcement are influenced by ambient temperature in both rodents and nonhuman primates (Gordon et al., 1991; Cornish et al., 2003; Banks et al., 2007 Banks et al., , 2008 Von Huben et al., 2007) . MDMAinduced thermogenesis in rodents is also thyroid hormone dependent (Sprague et al., 2003 . Clinically, there is a case report suggesting that hyperthyroidism potentiated the hyperthermic effects of ecstasy (Martin et al., 2007) . Currently, there is a void in our understanding of the effects of thyroid hormones on MDMA-induced thermogenesis and reinforcement in monkeys. Previously, we reported that elevating the ambient temperature produced changes in MDMA-induced thermodysregulation and increased the potency of MDMA reinforcement (Banks et al., 2007 (Banks et al., , 2008 . In this study, we hypothesized that elevating thyroid hormone levels would have similar effects as elevating the ambient temperature on MDMAinduced thermogenesis and the relative reinforcing strength of MDMA under a concurrent fixed-ratio (FR) schedule of MDMA and food choice. An advantage of concurrent schedules of reinforcement is that the dependent variable, drug choice, is less influenced by the direct effects of the drug on response rates and that response allocation is related to changes in reinforcement magnitude (Katz, 1990; Woolverton and Nader, 1990; Bergman and Paronis, 2006) .
Methods

Subjects
Four individually housed adult male rhesus monkeys (Macaca mulatta), surgically prepared with an indwelling intravenous catheter and a subcutaneous vascular access port (Access Technologies, Skokie, Illinois, USA; Martelle et al., 2007) , served as subjects. All monkeys were previously trained under a concurrent FR 30 schedule of food and MDMA (0.03-0.3 mg/kg/injection) presentation (Banks et al., 2008) . Monkeys were weighed biweekly and fed enough food daily (LabDiet #5038 Monkey Chow and fresh fruit) to maintain body weights at approximately 95% of free-feeding levels. Rectal temperatures were taken at least three times per week after Levo administration but before the behavioral session. The number of food pellets earned was calculated into the daily food requirements and monkeys were fed at least 2 h after completion of the experimental sessions. Environmental enrichment was provided as outlined in the Animal Care and Use Committee of Wake Forest University (WFU) Nonhuman Primate Environmental Enrichment Plan. All procedures were approved by the Animal Care and Use Committee of WFU and performed in accordance with the 2003 National Research Council Guidelines for the Care and Use of Mammals in Neuroscience and Behavioral Research.
Procedure
Experimental sessions were conducted in ventilated and sound-attenuating chambers (Med Associates, East Fairfield, Vermont, USA) with the ambient temperature inside the chamber maintained at 24 ± 11C as described previously (Banks et al., 2008) . Briefly, the skin above the venous access port was cleaned with betadine and 95% ethanol, and the port was connected to the infusion pump via a 22-gauge Huber point needle. At the beginning of each session, the pump was operated for approximately 3 s to fill the port and catheter with the concentration of MDMA or saline available for that session. Sessions began with illumination of lights above both levers. Thirty consecutive responses on a lever resulted in either a 10-s infusion or delivery of a 1-g banana-flavored pellet, followed by a 10-s timeout. The levers designated as food and drug were randomly determined for each monkey and remained constant throughout the experiment. Sessions ended after 30 total reinforcers had been earned or 60 min had elapsed. Each dose was available for at least five consecutive sessions and remained available until responding was deemed stable (percent injection-lever responding ± 20% of the mean of three consecutive sessions with no trend). Doses were tested in mixed order in each monkey.
After completion of the MDMA dose-response curve, the effects of Levo were examined. At the start of Levo (3.0 mg/kg/day, intramuscularly) treatment and for 10 consecutive days, responding was only maintained by food presentation under an FR 30 schedule of reinforcement before reinstituting MDMA self-administration. This dose of Levo was based on pilot data demonstrating behavioral effect as determined by a shift in the MDMA dose-effect curve. Levo treatment continued when the MDMA self-administration dose-response curve was redetermined after 10 days of Levo treatment. In two monkeys in which the dose-effect curve was not altered after the 3.0 mg/kg/day Levo treatment, the Levo dose was increased to 4.5 mg/kg/day for 10 days, and the MDMA dose-effect curve redetermined. During Levo treatment, all behavioral sessions began approximately 60 min after levothyroxine administration.
At the conclusion of the behavioral experiments, monkeys were challenged with noncontingent MDMA (1.5 mg/kg, intravenously) approximately 24 h after the last Levo injection to assess the effects of chronic Levo treatment on MDMA-induced thermogenesis. Rectal temperature was recorded for 3 h using a RET-1 rectal probe attached to a TH-3 thermocouple (Physitemp; Clifton, New Jersey, USA). For comparison, the effects of 1.5 mg/kg MDMA on thermogenesis in the absence of Levo treatment (Banks et al., 2007) are included in Fig. 1 and designated as euthyroid (Euth).
Drugs
Levothyroxine sodium (Bedford Laboratories, Bedford, Ohio, USA) was obtained from the WFU Baptist pharmacy and dissolved in sterile saline. ( ± )MDMA HCl was provided by the National Institute on Drug Abuse (Bethesda, Maryland, USA) and dissolved in sterile saline.
Plasma thyroxine levels assessment
Before and 10 days after initiating Levo treatment, venous blood (2 ml) was collected and transferred to a Vacutainer tube with no additives (Becton-Dickinson, Franklin Lakes, New Jersey, USA). Blood samples were centrifuged at 3000 rpm for 10 min at 41C, and thyroxine levels were determined by Antech Diagnostics (Lake Success, New York, USA).
Data analysis
Plasma thyroxine levels at baseline and after Levo were analyzed using a paired t-test. Temperature data were analyzed using a one-way ANOVA with time as the factor followed by a Dunnett post-hoc test comparing each time point to baseline (time 0). Behavioral data were analyzed with repeated measures mixed linear regression using SAS Proc Mixed (Version 8.2, SAS, Cary, North Carolina, USA) with Levo, MDMA dose and their interaction as factors. For the self-administration experiments, the primary dependent variables examined were MDMA choice (calculated by dividing the total number of MDMA-lever responses by the total responses on both levers), number of MDMA and food reinforcers earned per session. Differences were considered significant at the 95% level of confidence (P < 0.05).
Results
Effects of chronic Levo treatment on plasma thyroxine levels
Chronic Levo treatment significantly increased (t = 4.99, P < 0.05) plasma thyroxine levels on average 160% from baseline (6.3 ± 0.6 mg/dl; n = 4) in the absence of MDMA.
Effects of chronic Levo treatment on 3,4-methylenedioxymethamphetamine-induced changes in temperature
Chronic Levo treatment did not significantly change basal rectal temperature measured over the 3-month treatment period (38.3 ± 0.11C vs. 38.4 ± 0.21C). Administration of noncontingent ( ± ) MDMA (1.5 mg/kg, intravenously) at 241C significantly increased rectal temperature [F(6,27) = 3.16, P < 0.05; Fig. 1 ]. Post-hoc analysis revealed a significant (P < 0.05) change in rectal temperature at 15 and 30-min post-MDMA that returned to baseline at 60 min.
Effects of chronic Levo treatment on 3,4-methylenedioxymethamphetamine choice
Under baseline conditions, when the choice was between saline or a low dose of MDMA (0.03 mg/kg/injection) and food, monkeys primarily chose food ( Fig. 2a ; filled symbols). Increases in MDMA dose resulted in increases in MDMA choice, such that 0.1 and 0.3 mg/kg/injection MDMA were primarily (P < 0.05) chosen over food. A significant main effect of MDMA dose was present for MDMA choice [F(3,9) = 26.85, P < 0.05; Fig. 2a] , number of MDMA injections earned [F(3,9) = 6.81, P < 0.05; Fig. 2b ] and number of food pellets earned [F(3,9) = 30.7, P < 0.05; Fig. 2c ]. Chronic Levo treatment did not significantly alter any dependent measure.
Discussion
The rationale for these studies was based on the parallel effects of elevating the ambient temperature or thyroid hormone levels on potentiating MDMA-induced thermogenesis (Gordon et al., 1991; Sprague et al., 2003 Sprague et al., , 2007 . We had previously shown that noncontingent MDMA administration did not significantly change rectal temperature at 241C (Banks et al., 2007) . In this study, after chronic Levo treatment, MDMA administration at 241C did significantly increase rectal temperature. Although the topography of the thermogenic effect was different (peak thermogenic effect was 15 min) compared with elevating the ambient temperature under identical conditions (peak thermogenic effect was 90 min; Banks et al., 2007) , this finding confirms a parallel effect of elevating the ambient temperature and increasing thyroid hormone levels on MDMA-induced thermogenesis and extends the role of thyroid hormones in MDMA-induced thermogenesis to monkeys.
Preclinical research has demonstrated an interaction between ambient temperature and MDMA reinforcement (Cornish et al., 2003; Banks et al., 2008) . For example, elevating ambient temperature increased lowdose MDMA choice in the same monkeys used in this study under identical schedule conditions (Banks et al., 2008) . In contrast to the effects of elevating the ambient temperature, elevating thyroxine levels did not increase the relative reinforcing strength of MDMA despite having an effect on MDMA-induced thermogenesis. Individual differences were noted, unrelated to Levo dose. These findings support the contention that elevating thyroxine levels and elevating ambient temperature, which have parallel effects on MDMA-induced thermodysregulation, do not have similar consequences on MDMA reinforcement. The effects of ambient temperature on reinforcement appear not to be mediated through thermoregulatory mechanisms, such as the hypothalamicpituitary-thyroid axis.
